This could give enterprises access to a 3D, AI-accelerated future without requiring investment in costly GPU-scale ...

It is vital for biotech companies to run the right clinical trial and not cut costs with trial design or patient recruitment, ...

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

PI's new objective focusing stage excels in fast nano-focusing applications, such as DNA sequencing, laser-technology, wafer metrology, super-resolution microscopy, medical technology, and slide ...

Apar Industries Ltd, Symphony Ltd, Concord Biotech Ltd and Intellect Design Arena Ltd are among the other gainers in the BSE's 'A' group today, 08 May 2025.

4D-150 continues to be well tolerated during up to three years of follow-up in all patients (n=71) treated with 3E10 vg/eye dose, with the highest 4D-150-related intraocular inflammation (SUN/NEI ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of ...

Vladimir Putin and President of China Xi Jinping made statements for the media following Russian-Chinese talks.

Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof-of-concept, the ...